Chronic Lymphocytic Leukemia

>

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy.

Latest News

NX-5948 for R/R CLL/SLL | Image Credit: © Dr_Microbe - stock.adobe.com
EMA Grants PRIME Designation to NX-5948 for R/R CLL/SLL

November 21st 2024

NX-5948 has received PRIME designation from the EMA for the treatment of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

CLL, Image credit:   LASZLO– stock.adobe.com
Lisaftoclax NDA Accepted for Review in China for Relapsed/Refractory CLL/SLL

November 20th 2024

FDA
FDA Approves New Drug Labeling for Fludarabine Phosphate in CLL

November 20th 2024

Chronic Lymphocytic Leukemia
Piecing Together the Proper BTK Usage in CLL

November 13th 2024

First-Line Zanubrutinib in CLL/SLL
First-Line Zanubrutinib Prolongs PFS in Real-World Study of Chinese Patients With CLL/SLL

November 13th 2024

Latest CME Events & Activities

More News